The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals
Open accessAbstract
Persons symptomatic and at risk for Huntington's disease (HD) from a large extended family in the state of Zulia, Venezuela, have been followed prospectively for 7 years. Between 1981 and 1988, 593 people were examined, of whom 128 had symptomatic HD and 171 persons at risk had examination abnormalities that were insufficient to meet criteria for diagnosis. The remaining 294 had normal examinations. Abnormalities of saccadic eye movement and slowness of rapid alternating movements were the most common abnormalities found in at‐risk individuals. Thirty persons who did not meet criteria for diagnosis at their first examination have subsequently been diagnosed with symptomatic HD. Their average age at diagnosis was 33.5 ± 8.3 (SD) years. The likelihood of developing symptomatic HD within 3 years was 3% for those persons with normal first examinations, 23% for those with mildly abnormal first examinations, and 60% for those with highly abnormal first examinations. The rate of disease progression in early symptomatic cases were 1.4 ± 0.1 (SEM) points per year on the Shoulson‐Fahn functional capacity scale. Paternal or maternal inheritance did not appear to affect the rate of progression in this group of individuals. The data suggest that there is not a discrete age of onset but rather a prolonged period of time during which symptoms unfold.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huntington disease: Clinical care and evaluation
Shoulson, I., & Fahn, S. (1979) · Neurology · doi:10.1212/wnl.29.1.1 · Cited by 746
Self-citation
Cited by
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., Guttman, M., Johnson, S., MacDonald, M., Beglinger, L. J., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128728 · Cited by 804
Self-citationThe U.S.–Venezuela Collaborative Research Project*, & Wexler, N. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308679101 · Cited by 761
Self-citationSmith, M. A., & Shadmehr, R. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00943.2004 · Cited by 497
Mechanisms of neurodegeneration in Huntington’s disease
Gil, J. M., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 471
Rate of functional decline in Huntington’s disease
Marder, K., Zhao, H., Myers, R. H., Cudkowicz, M., Kayson, E., Kieburtz, K., Orme, C., Paulsen, J., Penney, J. B., Siemers, E., et al. (2000) · Neurology · doi:10.1212/wnl.54.2.452 · Cited by 362
Self-citationThe epidemiology of Huntington's disease
Harper, P. (1992) · Human Genetics · doi:10.1007/bf00194305 · Cited by 328
A randomized, placebo-controlled trial of coenzyme Q 10 and remacemide in Huntington’s disease
The Huntington Study Group (2001) · Neurology · doi:10.1212/wnl.57.3.397 · Cited by 312
Progression of Symptoms in the Early and Middle Stages of Huntington Disease
Kirkwood, S. C., Su, J. L., Conneally, P. M., & Foroud, T. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.273 · Cited by 269
Self-citationDepression and Stages of Huntington's Disease
Paulsen, J. S. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.4.496 · Cited by 267
A controlled trial of idebenone in Huntington's disease
Ranen, N. G., Peyser, C. E., Coyle, J. T., Bylsma, F. W., Sherr, M., Day, L., Folstein, M. F., Brandt, J., Ross, C. A., & Folstein, S. E. (1996) · Movement Disorders · doi:10.1002/mds.870110510 · Cited by 97
Early sympathetic hyperactivity in Huntington's disease
Kobal, J., Meglič, B., Mesec, A., & Peterlin, B. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00894.x · Cited by 70
Forgotten frontal lobe syndrome or “Executive Dysfunction Syndrome”
Lyketsos, C. G., Rosenblatt, A., & Rabins, P. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.3.247 · Cited by 53
Louis, E. D., Levy, G., Côte, L. J., Mejia, H., Fahn, S., & Marder, K. (2002) · Movement Disorders · doi:10.1002/mds.10119 · Cited by 41
Psychogenic movement disorders
Fahn, S., Jankovic, J., & Hallett, M. (2011) · Principles and Practice of Movement Disorders · doi:10.1016/b978-1-4377-2369-4.00025-1 · Cited by 37
(2006) · PubMed
Metadata
- Authors
- Penney, J. B., Young, A. B., Shoulson, I., Starosta‐Rubenstein, S., Snodgrass, S. R., Sanchez‐Ramos, J., Ramos‐Arroyo, M., Gomez, F., Penchaszadeh, G., Alvir, J., Esteves, J., DeQuiroz, I., Marsol, N., Moreno, H., Conneally, P. M., Bonilla, E., & Wexler, N. S.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1990-01
- Volume
- 5
- Issue
- 2
- Pages
- 93-99
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2166224121
- Cited by
- 218
- References
- 1
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.